Research Article

The Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, No. 1, Dahua Road, Dongdan, Beijing 100730, PR China and Graduate School, Wenzhou Medical University, University-town, Wenzhou, Zhejiang 325035, PR China

^‡Authors contributed equally

Xin-Min Xu^‡

The Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, No. 1, Dahua Road, Dongdan, Beijing 100730, PR China and Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, PR China

^‡Authors contributed equally

Search for more papers by this author

Guo-Xin Hu^‡

Department of Pharmacology, Wenzhou Medical University, University-town, Wenzhou, Zhejiang 325035, PR China

^‡Authors contributed equally

Search for more papers by this author

Da-Peng Dai^‡

The Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, No. 1, Dahua Road, Dongdan, Beijing 100730, PR China

^‡Authors contributed equally

Search for more papers by this author

Ren-Ai Xu

Graduate School, Wenzhou Medical University, University-town, Wenzhou, Zhejiang 325035, PR China and Department of Pharmacology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR China

Search for more papers by this author

Li-Ming Hu

Graduate School, Wenzhou Medical University, University-town, Wenzhou, Zhejiang 325035, PR China

Search for more papers by this author

Fang-Hong Li

Center of Healthcare, Wenzhou Medical University, University-town, Wenzhou, Zhejiang 325035, PR China

Search for more papers by this author

Xiu-Hua Zhang

Department of Pharmacology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR China

Search for more papers by this author

Jie-Fu Yang^§

Department of Cardiology, Beijing Hospital, Ministry of Health, No. 1, Dahua Road, Dongdan, Beijing, 100730, PR China

^§Authors contributed equally

Search for more papers by this author

Jian-Ping Cai^§

* Author for correspondence

The Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, No. 1, Dahua Road, Dongdan, Beijing 100730, PR China.

^§Authors contributed equally

Search for more papers by this author

Email the corresponding author at caijp61@vip.sina.com

Published Online:5 Nov 2013https://doi.org/10.2217/pgs.13.160

View article

Abstract

Aim: The purpose of this study was to determine the genetic polymorphisms of the CYP2D6 gene and to elucidate the allele distribution pattern in the Chinese Han population. Materials & methods: We used PCR and bidirectional sequencing methods to analyze all nine exons of the CYP2D6 gene in 2129 unrelated, healthy Chinese Han subjects from two geographical locations in China: the northern and southern regions. Results: In total, 165 mutated sites were detected in 2129 participants, of which 67 sites were reported for the first time. Among these novel mutation sites, 22 were nonsynonymous and 12 were named as novel alleles (*87–*93, *94A, *94B and *95–*98) by the Human CYP Allele Nomenclature Committee. In addition, 29 previously reported alleles and 84 genotypes were also detected in 1954 volunteers. Functional prediction of novel variants revealed that eight variants might have a deleterious effect on CYP2D6. Linkage disequilibrium analysis and tagSNP selection were performed separately. By using these methods, distinct differences were found between the two regions. Conclusion: This study provides the most comprehensive data concerning CYP2D6 polymorphisms in the Chinese Han population to date and increases the number of known alleles; these findings may greatly contribute to the development of personalized medicine for the Chinese Han population.

Original submitted 1 January 2013; Revision submitted 14 August 2013

Keywords:

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

1 Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology – with emphasis on cytochrome P450. Toxicol. Sci.120(1),1–13 (2011).
Medline CASGoogle Scholar
2 Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet360(9340),1155–1162 (2002).
Medline CASGoogle Scholar
3 Nelson DR. The cytochrome P450 homepage. Hum. Genomics4(1),59–65 (2009).
Medline CASGoogle Scholar
4 Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics14(1),1–18 (2004).
Medline CASGoogle Scholar
5 O’Reilly E, Kohler V, Flitsch SL, Turner NJ. Cytochromes P450 as useful biocatalysts: addressing the limitations. Chem. Commun. (Camb.)47(9),2490–2501 (2011).
MedlineGoogle Scholar
6 Zanger UM, Raimundo S, Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch. Pharmacol.369(1),23–37 (2004).▪▪ Discusses CYP2D6 genotypes, phenotypes and clinical applications in detail.
Medline CASGoogle Scholar
7 Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Inter individual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther.270(1),414–423 (1994).
Medline CASGoogle Scholar
8 Ingelman-Sundberg M. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol. Sci.25,193–200 (2004).
Medline CASGoogle Scholar
9 Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev.34(1–2),83–448 (2002).
Medline CASGoogle Scholar
10 Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur. J. Clin. Pharmacol.16(3),183–187 (1979).
Medline CASGoogle Scholar
11 Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL. Polymorphic hydroxylation of debrisoquine in man. Lancet2(8038),584–586 (1977).
Medline CASGoogle Scholar
12 Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J. Pharmacol. Exp. Ther.278(1),441–446 (1996).
Medline CASGoogle Scholar
13 Gaedigk A, Eklund JD, Pearce RE et al. Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype. Clin. Pharmacol. Ther.81(6),817–820 (2007).
Medline CASGoogle Scholar
14 Kagimoto M, Heim M, Kagimoto K, Zeugin T, Meyer UA. Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. J. Biol. Chem.265(28),17209–17214 (1990).
Medline CASGoogle Scholar
15 Marez D, Legrand M, Sabbagh N et al. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics7(3),193–202 (1997).
Medline CASGoogle Scholar
16 Raimundo S, Fischer J, Eichelbaum M, Griese EU, Schwab M, Zanger UM. Elucidation of the genetic basis of the common ‘intermediate metabolizer’ phenotype for drug oxidation by CYP2D6. Pharmacogenetics10(7),577–581 (2000).
Medline CASGoogle Scholar
17 Gough AC, Smith CA, Howell SM, Wolf CR, Bryant SP, Spurr NK. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis. Genomics15(2),430–432 (1993).
Medline CASGoogle Scholar
18 Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am. J. Hum. Genet.45(6),889–904 (1989).
Medline CASGoogle Scholar
19 Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther.116(3),496–526 (2007).
Medline CASGoogle Scholar
20 Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics3(2),229–243 (2002).▪ Discusses the frequencies of CYP2D6 alleles in different races.
CASGoogle Scholar
21 Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet. Genomics17(2),93–101 (2007).
Medline CASGoogle Scholar
22 Yin SJ, Ni YB, Wang SM, Wang X, Lou YQ, Zhang GL. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. J. Clin. Pharm. Ther.37(3),364–369 (2012).
Medline CASGoogle Scholar
23 Zuo LJ, Guo T, Xia DY, Jia LH. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations. Genet. Test. Mol. Biomarkers16(2),102–108 (2012).
Medline CASGoogle Scholar
24 Ji L, Pan S, Wu J, Marti-Jaun J, Hersberger M. Genetic polymorphisms of CYP2D6 in Chinese mainland. Chin. Med. J. (Engl.)115(12),1780–1784 (2002).
Medline CASGoogle Scholar
25 Li Q, Wang R, Guo Y, Wen S, Xu L, Wang S. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers. J. Clin. Pharm. Ther.35(2),239–247 (2010).
Medline CASGoogle Scholar
26 Qin S, Shen L, Zhang A et al. Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China. Genomics92(3),152–158 (2008).▪ First large-scale investigation of the CYP2D6 gene in Han populations.
Medline CASGoogle Scholar
27 Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin. Pharmacokinet.48(11),689–723 (2009).
Medline CASGoogle Scholar
28 Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin. Pharmacokinet.48(11),761–804 (2009).
Medline CASGoogle Scholar
29 Mizutani T. PM frequencies of major CYPs in Asians and Caucasians. Drug Metab. Rev.35(2–3),99–106 (2003).
Medline CASGoogle Scholar
30 Neafsey P, Ginsberg G, Hattis D, Sonawane B. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6), population distribution of CYP2D6 activity. J. Toxicol. Environ. Health B Crit. Rev.12(5–6),334–361 (2009).
Medline CASGoogle Scholar
31 Hersberger M, Marti-Jaun J, Rentsch K, Hanseler E. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin. Chem.46(8 Pt 1),1072–1077 (2000).▪ Introduced the method of rapid detection for the CYP2D6*5 allele by PCR.
Medline CASGoogle Scholar
32 Lovlie R, Daly AK, Molven A, Idle JR, Steen VM. Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett.392(1),30–34 (1996).▪ Introduced a reliable method of detecting alleles with duplicated CYP2D6 genes.
Medline CASGoogle Scholar
33 Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nat. Methods7(4),248–249 (2010).
Medline CASGoogle Scholar
34 Chen J, Zheng H, Bei JX et al. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am. J. Hum. Genet.85(6),775–785 (2009).
Medline CASGoogle Scholar
35 Wang B, Yang LP, Zhang XZ, Huang SQ, Bartlam M, Zhou SF. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. Drug Metab. Rev.41(4),573–643 (2009).
Medline CASGoogle Scholar
36 Garcia-Barcelo M, Chow LY, Chiu HF et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin. Chem.46(1),18–23 (2000).
Medline CASGoogle Scholar
37 Lee SJ, Lee SS, Jung HJ et al. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans. Drug Metab. Dispos.37(7),1464–1470 (2009).
Medline CASGoogle Scholar
38 Yue QY, Svensson JO, Sawe J, Bertilsson L. Codeine metabolism in three oriental populations: a pilot study in Chinese, Japanese and Koreans. Pharmacogenetics5(3),173–177 (1995).
Medline CASGoogle Scholar
39 Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet.60(2),284–295 (1997).
Medline CASGoogle Scholar
40 Scordo MG, Caputi AP, D’Arrigo C, Fava G, Spina E. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol. Res.50(2),195–200 (2004).
Medline CASGoogle Scholar
41 Gaedigk A, Gotschall RR, Forbes NS, Simon SD, Kearns GL, Leeder JS. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics9(6),669–682 (1999).
Medline CASGoogle Scholar
42 Llerena A, Dorado P, Calzadilla LR et al.CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. Pharmacogenomics J.12(2),176–183 (2012).
Medline CASGoogle Scholar
43 Isaza CA, Henao J, López AM, Cacabelos R. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. Methods Find. Exp. Clin. Pharmacol.22(9),695–705 (2000).
Medline CASGoogle Scholar
44 Dorado P, Heras N, Machín E, Hernández F, Teran E, Llerena A. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population. Eur. J. Clin. Pharmacol.68(5),637–644 (2012).
MedlineGoogle Scholar
45 Wennerholm A, Johansson I, Massele AY et al. Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype. Pharmacogenetics9(6),707–714 (1999).
Medline CASGoogle Scholar
46 Kleywegt GJ, Jones TA. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D Biol. Crystallogr.50(Pt 2),178–185 (1994).
Medline CASGoogle Scholar
47 Rowland P, Blaney FE, Smyth MG et al. Crystal structure of human cytochrome P450 2D6. J. Biol. Chem.281(11),7614–7622 (2006).▪ Investigated the crystal structure of CYP2D6 and defined its active site cavity.
Medline CASGoogle Scholar
101 CYP2D6 allele nomenclature. www.cypalleles.ki.se/cyp2d6.htm
Google Scholar
102 Protein data bank-2F9Q. www.rcsb.org/pdb/explore/explore.do?structureId=2F9Q
Google Scholar
103 RNA splicing. www.fruitfly.org/seq_tools/splice.html
Google Scholar
104 PolyPhen-2. http://genetics.bwh.harvard.edu/pph2
Google Scholar
105 Arlequin 3.5 program. http://cmpg.unibe.ch/software/arlequin3
Google Scholar
106 Haploview. www.broadinstitute.org/scientific-community/software
Google Scholar

Vol. 14, No. 14

Supplemental Materials

Metrics

Downloaded 593 times

History

Published online 5 November 2013

Published in print November 2013

Information

Keywords

Financial & competing interests disclosure

This work was supported by the National Department Public Benefit Research Foundation by Ministry of Health PR China (No. 201302008) and the National Key Project for New Drug Investigations (2012ZX09303008), which were founded by the Ministry of Science and Technology of the People’s Republic of China. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Helsinki Declaration for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

PDF download

Genetic variations of human CYP2D6 in the Chinese Han population

Abstract

References